About NovoCure

Novocure is a private company supported by institutional, individual, and strategic investors. Key investors include WFD Ventures, Index Ventures, and Lennart Perlhagen, founder of Swedish pharmaceutical company Meda AB (Nasdaq OMX Nordic Exchange: MEDAA). The company has also received equity investments from Pfizer Venture Investments and Johnson & – more... 

Claim this company page
Headquarters
Portsmouth New Hampshire, United States
Revenue
$7 Million
Employees
11 to 50
Industry
Links
NovoCure website